Edition:
India

People: CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

17.40HKD
18 Oct 2019
Change (% chg)

HK$0.50 (+2.96%)
Prev Close
HK$16.90
Open
HK$16.92
Day's High
HK$17.58
Day's Low
HK$16.84
Volume
33,956,018
Avg. Vol
37,147,098
52-wk High
HK$19.26
52-wk Low
HK$9.90

Li, Chunlei 

Mr. Li Chunlei is Executive Director of the Company. Dr. Li is currently the Chief Scientist of the Group in charge of research and development. Dr. Li is also the general manager of a subsidiary of the Company, deputy director of the Novel Pharmaceutical Preparations and Excipients State Key Laboratory and director of the Hebei Pharmaceutical Engineering Technology Centre. Dr. Li holds a bachelor’s degree in engineering (biological pharmaceutics) from Jilin University and Shenyang Pharmaceutical University, a master’s degree in science (microbial and biochemical pharmaceutics) from Jilin University and a doctorate in science (pharmaceutical science) from Shenyang Pharmaceutical University.

Basic Compensation

Total Annual Compensation, HKD 4,704,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 79,000
Fiscal Year Total, HKD 4,783,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dongchen Cai

13,805,000

Cuilong Zhang

4,326,000

Kin Man Chak

5,269,000

Chunlei Li

4,783,000

Hua Lu

4,205,000

Weidong Pan

4,387,000
As Of  31 Dec 2018